News & Events


Published on 13 April 2017

Studies show DBT detects more breast cancers than mammo

Digital breast tomosynthesis (DBT) identifies more breast cancers than conventional digital mammography, according to two studies presented at ECR 2017. In addition, the recall rates between the two modalities are comparable, researchers found.

Published on 17 March 2017

Screening mammografico: avanti tutta con la sperimentazione

La Regione Piemonte a supporto dei progetti “Proteus donna” e “Sperimentazione di screening DBT” (inseriti all’interno di Prevenzione Serena e già in corso di svolgimento presso una decina di Aziende Sanitarie piemontesi), ha esteso fino al 31 dicembre 2017 la convenzione siglata con l’Università degli Studi di Torino, l’Azienda Ospedaliera-Universitaria Città della Salute e della Scienza di Torino, il CSI Piemonte, la Im3d Scarl e la Fondazione Edo ed Elvio Tempia Valenta.

Published on 20 January 2014

CAD provides boost for digital breast tomosynthesis

Digital breast tomosynthesis (DBT) has been praised as a powerful tool in the breast imaging armamentarium, but these 3D studies can also be time-consuming and complicated for radiologists to interpret. im3D Computer-aided detection (CAD) technology may be of assistance, Italian researchers have found.

Published on 3 September 2014

DBT plus 2D mammography improves radiologist performance

The clinical performance of radiologists improves when digital breast tomosynthesis (DBT) is combined with conventional 2D full-field digital mammography (FFDM) for breast cancer screening, according to research published in the September issue of Academic Radiology.

Published on 29 October 2014

DBT screening shows greatest benefit for younger women

Digital breast tomosynthesis (DBT) shows its greatest benefit when used to screen women younger than 50, according to research published October 13 in the Journal of the National Cancer Institute. DBT was effective in reducing recalls and increasing cancer detection in these younger women, who have been at the center of the controversy over breast screening.

Published on 19 November 2014

Proteus Colon presentation at RSNA 2014 (Chicago)

Screening for Colorectal Cancer: Results of the Proteus Colon Screening trial for Colorectal cancer will be presented at RSNA 2014. Proteus Colon is a randomized trial comparing comparing Flexible Sigmoidoscopy (FS) with CT Colonography (CTC), based on im3D CAD COLON technology. In the talk, differences in participation rate between FS and CTC in a population-based colorectal cancer (CRC) screening program in Turin, Italy, will be discussed.
Presentation will take place on Dicember 3rd at 10.50am in room E351.

Published on 4 December 2014

DBT finds 30% more cancer than mammo in dense breast tissue

Adding digital breast tomosynthesis (DBT) to full-field digital mammography (FFDM) improves cancer detection in women with dense breast tissue by 30% versus mammography alone, according to research presented on Tuesday at the RSNA 2014 meeting.

Published on 13 January 2015

Tomo plus digital mammography decreases recalls by 37%

Adding tomosynthesis to digital mammography for breast cancer screening reduces recall rates by 37%, with the technique recording better performance for certain types of breast abnormalities, according to a new study in the January issue of Radiology.

Published on 6 March 2015

Italian men shun flexible sigmoidoscopy for CTC

Whether it's fear of endoscopes or love of high technology, Italian men appear more willing to undergo CT colonography (CTC) than flexible sigmoidoscopy, according to the results of a late-breaking trial presented at ECR 2015.

Published on 4 May 2015

Study demonstrates value of im3D automatic Breast Density assessment tool

613 screening/diagnostic digital mammograms from nine centers and six different vendors have been assessed by twenty-one experienced breast radiologists and then evaluated by im3D QUID tool for automatic breast density assessment. 

QUID showed an almost perfect agreement with the radiologists panel in breast density classification, establishing its role as a reproducible, vendor-neutral and effective alternative to visual evaluation.